Table 1 HA levels in patients serum samples
From: Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
Tissue | n | Patient age (years) Median (range) | HA serum level (μg/ml) Median (range) | |
|---|---|---|---|---|
Normal ovaries | 27 | 50 (48–58) | 9.6 (0.6–114.3) | |
Benign ovarian tumors | 22 | 51 (35–62) | 17.3 (1–136.5) | |
Ovarian cancers | Total | 101 | 61 (25–90) | 28.7 (0.3–1543.7) |
Serous | 59 | 61 (25–85) | 26.7 (0.3–172.8) | |
Endometrioid | 16 | 55 (33–90) | 37.0 (4.2–1543.9) | |
Mucinous | 7 | 54 (37–74) | 26.2 (1.5–70.7) | |
Clear Cell | 9 | 62 (37–82) | 25.9 (2.2–101.9) | |
Others | 10 | 60 (32–88) | 25.5 (13.6–111.9) | |
Stage | Â | Â | Â | |
1 | 31 | 55 (33–90) | 26.0 (1.1–1543.7) | |
2 | 6 | 59 (44–65) | 19.0 (1.5–37.0) | |
3 | 58 | 62 (25–88) | 29.6 (0.3–172.8) | |
|  | 4 | 4 | 64 (61–79) | 19.8 (15.8–89.3) |